• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Azenta Reports Upbeat Earnings, Joins Talis Biomedical, Sally Beauty And Other Big Stocks Moving Higher On Tuesday

    11/14/23 10:39:13 AM ET
    $ACCD
    $ADPT
    $AFRM
    $AGTI
    Business Services
    Consumer Discretionary
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care
    Get the next $ACCD alert in real time by email

    U.S. stocks traded higher, with the Dow Jones gaining around 500 points on Tuesday.

    Shares of Azenta, Inc. (NASDAQ:AZTA) rose on Tuesday after the company reported better-than-expected fourth-quarter financial results.

    Azenta posted adjusted earnings of 13 cents per share, beating market estimates of 2 cents per share. The company’s quarterly sales came in $172.36 million versus estimates of $163.9 million.

    Azenta shares rose 15.1% to $55.05 on Tuesday.

    Here are some big stocks recording gains in today’s session.

    Talis Biomedical Corporation (NASDAQ:TLIS) shares rose 33.4% to $7.19 as the company announced exploration of strategic alternatives and cost reduction plan to preserve cash.

    PureCycle Technologies, Inc. (NASDAQ:PCT) rose 27.7% to $3.91.

    Paysafe Limited (NYSE:PSFE) gained 21.2% to $12.97 following upbeat earnings.

    Sunnova Energy International Inc. (NYSE:NOVA) rose 18.5% to $10.10.

    Sally Beauty Holdings, Inc. (NYSE:SBH) gained 15.5% to $9.39 following fourth-quarter earnings.

    Adaptive Biotechnologies Corporation (NASDAQ:ADPT) climbed 15.1% to $3.9750. Piper Sandler maintained Adaptive Biotechnologies with an Overweight and lowered the price target from $13 to $6.

    Ameresco, Inc. (NASDAQ:AMRC) rose 15.1% to $25.92.

    Janux Therapeutics, Inc. (NASDAQ:JANX) jumped 14.3% to $8.10.

    SL Green Realty Corp. (NYSE:SLG) gained 14% to $33.75.

    Plug Power Inc. (NASDAQ:PLUG) gained 13.8% to $3.95.

    Uniti Group Inc. (NASDAQ:UNIT) surged 13.6% to $5.17.

    Sunrun Inc. (NASDAQ:RUN) gained 13.5% to $10.48.

    Vornado Realty Trust (NYSE:VNO) gained 13.3% to $22.60.

    Holley Inc. (NYSE:HLLY) gained 12.9% to $4.20.

    Accolade, Inc. (NASDAQ:ACCD) jumped 12.8% to $7.78.

    Arvinas, Inc. (NASDAQ:ARVN) climbed 12.7% to $18.70.

    COMPASS Pathways plc (NASDAQ:CMPS) gained 12.5% to $5.93.

    Affirm Holdings, Inc. (NASDAQ:AFRM) climbed 12.4% to $25.72.

    Pacific Biosciences of California, Inc. (NASDAQ:PACB) surged 12.3% to $7.24.

    V.F. Corporation (NYSE:VFC) gained 11.5% to $15.77.

    The E.W. Scripps Company (NASDAQ:SSP) gained 11% to $7.35.

    Agiliti, Inc. (NASDAQ:AGTI) gained 10.7% to $7.57. UBS upgraded Agiliti from Neutral to Buy and lowered the price target from $16 to $10.

    Axos Financial, Inc. (NYSE:AX) climbed 10.6% to $36.90.

    Zions Bancorporation, National Association (NASDAQ:ZION) gained 9.6% to $35.87.

    KeyCorp (NYSE:KEY) gained 9.5% to $11.89.

    Zillow Group, Inc. (NASDAQ:Z) climbed 9.2% to $38.98. PHH Mortgage announced new subservicing agreement with Zillow Home Loans.

    Snap Inc. (NYSE:SNAP) gained 9% to $12.32 following reports suggesting Amazon has reached a deal to run shopping ads on the app.

    Now Read This: Bitcoin, Ethereum Move Lower Following CPI Data; Cosmos Becomes Top Loser

    Get the next $ACCD alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ACCD
    $ADPT
    $AFRM
    $AGTI

    CompanyDatePrice TargetRatingAnalyst
    Janux Therapeutics Inc.
    $JANX
    4/15/2026$15.00Buy → Neutral
    UBS
    Snap Inc.
    $SNAP
    4/14/2026$7.00 → $6.00Hold
    Canaccord Genuity
    V.F. Corporation
    $VFC
    4/14/2026$24.00Neutral → Buy
    Seaport Research Partners
    Axos Financial Inc.
    $AX
    4/7/2026$100.00Outperform → Strong Buy
    Raymond James
    SL Green Realty Corp
    $SLG
    3/18/2026$44.00Hold → Buy
    Deutsche Bank
    Zions Bancorporation N.A.
    $ZION
    3/12/2026Neutral
    Brean Capital
    Zions Bancorporation N.A.
    $ZION
    3/9/2026$65.00Neutral → Outperform
    Robert W. Baird
    Pacific Biosciences of California Inc.
    $PACB
    3/6/2026$1.50Equal Weight → Underweight
    Barclays
    More analyst ratings

    $ACCD
    $ADPT
    $AFRM
    $AGTI
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Rubinstein Julie

    4 - Adaptive Biotechnologies Corp (0001478320) (Issuer)

    4/16/26 7:36:22 PM ET
    $ADPT
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    SEC Form 3 filed by new insider Martin William E. Iii

    3 - Azenta, Inc. (0000933974) (Issuer)

    4/16/26 6:48:00 PM ET
    $AZTA
    Industrial Machinery/Components
    Technology

    SEC Form 4 filed by Watson Noel Bertram

    4 - Affirm Holdings, Inc. (0001820953) (Issuer)

    4/16/26 4:19:09 PM ET
    $AFRM
    Finance: Consumer Services
    Finance

    $ACCD
    $ADPT
    $AFRM
    $AGTI
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Janux Therapeutics downgraded by UBS with a new price target

    UBS downgraded Janux Therapeutics from Buy to Neutral and set a new price target of $15.00

    4/15/26 8:07:01 AM ET
    $JANX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Canaccord Genuity reiterated coverage on Snap with a new price target

    Canaccord Genuity reiterated coverage of Snap with a rating of Hold and set a new price target of $6.00 from $7.00 previously

    4/14/26 1:08:30 PM ET
    $SNAP
    Computer Software: Programming Data Processing
    Technology

    V.F. Corp upgraded by Seaport Research Partners with a new price target

    Seaport Research Partners upgraded V.F. Corp from Neutral to Buy and set a new price target of $24.00

    4/14/26 8:13:41 AM ET
    $VFC
    Garments and Clothing
    Industrials

    $ACCD
    $ADPT
    $AFRM
    $AGTI
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    June 7, 2024 - FDA Roundup: June 7, 2024

    For Immediate Release: June 07, 2024 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:  Today, the FDA announced that it has advised the manufacturers of the licensed and authorized COVID-19 vaccines that the COVID-19 vaccines (2024-2025 Formula) for use in the United States should be monovalent (single strain) JN.1 vaccines to more closely match cu

    6/7/24 3:46:22 PM ET
    $GERN
    $SRAX
    $SNAP
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Advertising
    Consumer Discretionary

    March 22, 2024 - FDA Roundup: March 22, 2024

    For Immediate Release: March 22, 2024 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:  Today, the FDA issued an emergency use authorization for Pemgarda (pemivibart) for the pre-exposure prophylaxis (prevention) of COVID-19 in certain adults and adolescents (12 years of age and older weighing at least 40 kilograms [about 88 pounds]).  Pemgarda is

    3/22/24 5:02:42 PM ET
    $SNAP
    $SRAX
    Computer Software: Programming Data Processing
    Technology
    Advertising
    Consumer Discretionary

    November 9, 2023 - FDA Approves First Treatment for Patients with Rare Inherited Blood Clotting Disorder

    For Immediate Release: November 09, 2023 Today, the U.S. Food and Drug Administration approved Adzynma, the first recombinant (genetically engineered) protein product indicated for prophylactic (preventive) or on demand enzyme replacement therapy (ERT) in adult and pediatric patients with congenital thrombotic thrombocytopenic purpura (cTTP), a rare and life-threatening blood clotting disorder. “The FDA remains

    11/9/23 2:30:20 PM ET
    $SRAX
    $SNAP
    Advertising
    Consumer Discretionary
    Computer Software: Programming Data Processing
    Technology

    $ACCD
    $ADPT
    $AFRM
    $AGTI
    SEC Filings

    View All

    PureCycle Technologies Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Material Modification to Rights of Security Holders, Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits

    8-K - PureCycle Technologies, Inc. (0001830033) (Filer)

    4/17/26 8:30:23 AM ET
    $PCT
    Major Chemicals
    Industrials

    SEC Form 144 filed by Snap Inc.

    144 - Snap Inc (0001564408) (Subject)

    4/16/26 4:02:22 PM ET
    $SNAP
    Computer Software: Programming Data Processing
    Technology

    SL Green Realty Corp filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - SL GREEN REALTY CORP (0001040971) (Filer)

    4/16/26 1:43:26 PM ET
    $SLG
    Real Estate Investment Trusts
    Real Estate

    $ACCD
    $ADPT
    $AFRM
    $AGTI
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Tisch Daniel R bought $766,500 worth of shares (30,000 units at $25.55), increasing direct ownership by 16% to 215,000 units (SEC Form 4)

    4 - VORNADO REALTY TRUST (0000899689) (Issuer)

    3/16/26 4:51:22 PM ET
    $VNO
    Real Estate Investment Trusts
    Real Estate

    Large owner Granado Anthony S. bought $19,289 worth of Class A Common Shares (4,200 units at $4.59), increasing direct ownership by 10% to 45,712 units (SEC Form 4)

    4 - E.W. SCRIPPS Co (0000832428) (Issuer)

    3/11/26 6:30:08 PM ET
    $SSP
    Broadcasting
    Industrials

    Large owner Brickner Savannah bought $298,012 worth of Class A Common Shares (66,226 units at $4.50) (SEC Form 4)

    4 - E.W. SCRIPPS Co (0000832428) (Issuer)

    3/11/26 6:30:13 PM ET
    $SSP
    Broadcasting
    Industrials

    $ACCD
    $ADPT
    $AFRM
    $AGTI
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Affirm to announce third quarter fiscal year 2026 results on May 7, 2026

    Affirm Holdings, Inc. (NASDAQ:AFRM) today announced it will publish its third quarter fiscal year 2026 shareholder letter, including its financial results, on its investor relations website at https://investors.affirm.com/ on Thursday, May 7, 2026, after market close. The Company will host a conference call and webcast at 2:00pm PT that same day. Hosting the call will be Max Levchin (Founder and Chief Executive Officer), Michael Linford (Chief Operating Officer), and Rob O'Hare (Chief Financial Officer). A replay will be available on the investor relations website following the call. About Affirm Affirm's mission is to deliver honest financial products that improve lives. By building

    4/16/26 4:07:00 PM ET
    $AFRM
    Finance: Consumer Services
    Finance

    PacBio to Report First Quarter 2026 Financial Results on May 7, 2026

    MENLO PARK, Calif., April 16, 2026 (GLOBE NEWSWIRE) -- PacBio (NASDAQ:PACB) announced today that it will hold its quarterly conference call to discuss its first quarter 2026 financial results on Thursday, May 7, 2026, at 4:30 p.m. Eastern Time (1:30 p.m. Pacific Time). The call will be webcast and may be accessed on PacBio's website at https://investor.pacificbiosciences.com/. Date: Thursday, May 7, 2026, at 4:30 p.m. ET (1:30 p.m. PT)Listen live via internet or replay: https://investor.pacificbiosciences.com/ Toll-free: 1-888-349-0136 International: 1-412-317-0459 About PacBio PacBio (NASDAQ:PACB) is a premier life science technology company that designs, develops, and manufactures a

    4/16/26 4:05:00 PM ET
    $PACB
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    Janux Therapeutics Announces First Participant Dosed in Phase 1 Study of JANX014

    -JANX014 expands Janux's PSMA tumor-activated T cell engager portfolio -JANX007 is the Company's lead prostate cancer program and primary development priority -JANX013, a PSMA-TRACIr CD28 co-stimulatory program, planned to enter the clinic in 2H2026 Janux Therapeutics, Inc. (NASDAQ:JANX) (Janux), a clinical-stage biopharmaceutical company developing a broad pipeline of novel immunotherapies, today announced that the first patient has been dosed in a Phase 1 clinical trial of JANX014 in patients with metastatic castration-resistant prostate cancer (mCRPC). JANX014 is a double-masked, prostate-specific membrane antigen (PSMA) directed T cell engager (TCE) designed to leverage Janux's tu

    4/16/26 4:01:00 PM ET
    $JANX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ACCD
    $ADPT
    $AFRM
    $AGTI
    Leadership Updates

    Live Leadership Updates

    View All

    CoinShares Appoints Paul Grinberg as Chairman and Announces Full Board of Directors Following Nasdaq Listing

    Board composition includes former acting CFTC Chair Caroline D. Pham and seasoned financial institution executive Christopher D. Myers, meeting Nasdaq independence standards SAINT HELIER, Jersey — April 16, 2026 — CoinShares PLC ("CoinShares" or "the Group") (NASDAQ:CSHR), a leading global asset manager specializing in digital assets, today announced the composition of its Board of Directors, effective March 31, 2026. The Board comprises five directors, three of whom are independent, meeting Nasdaq listing standards. Paul Grinberg has been appointed Chairman of the Board and Chairman of the Audit Committee. The announcement follows CoinShares' completion of its Nasdaq listing on April 1, 2

    4/16/26 7:00:00 AM ET
    $AX
    $CSHR
    $CVBF
    Savings Institutions
    Finance
    Investment Bankers/Brokers/Service
    Major Banks

    Azenta Life Sciences Announces Leadership Transition to Accelerate Gene Synthesis Strategy and Multiomics Execution

    BURLINGTON, Mass., April 7, 2026 /PRNewswire/ -- Azenta, Inc. (NASDAQ:AZTA) today announced the appointment of Trey Martin as President of its Multiomics business, effective April 6, 2026. In this role, Mr. Martin will lead the Multiomics organization and report to John Marotta, Azenta's President and Chief Executive Officer.This appointment is aimed at accelerating execution of Azenta's Multiomics long-range plan, outlined at its December 2025 Investor Day, with a continued focus on scaling global synthesis capabilities, strengthening operational excellence, enhancing commercial discipline, and driving profitable growth across the integrated Multiomics platform to support broader market ado

    4/7/26 8:15:00 AM ET
    $AZTA
    Industrial Machinery/Components
    Technology

    Sally Beauty Holdings Appoints Adrianne Lee as Chief Financial Officer

    Marlo Cormier to Step Down to Pursue Other Opportunities Reaffirms Second Quarter and Fiscal Year 2026 Guidance Sally Beauty Holdings, Inc. (NYSE:SBH) ("the Company") today announced that Adrianne Lee has been appointed Senior Vice President and Chief Financial Officer, effective April 28, 2026. Ms. Lee succeeds Marlo Cormier, who will be leaving the company, effective April 11, 2026, to pursue other opportunities. Ms. Lee brings significant relevant experience to the role, most recently serving as President and CFO at Bed Bath & Beyond. Ms. Lee joined Bed Bath & Beyond as CFO in 2020 and became Chief Administrative Officer in 2024 and President in 2025. Prior to that, she held senior

    4/2/26 6:45:00 AM ET
    $SBH
    Other Specialty Stores
    Consumer Discretionary

    $ACCD
    $ADPT
    $AFRM
    $AGTI
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by KeyCorp

    SC 13D/A - KEYCORP /NEW/ (0000091576) ()

    1/5/94 12:00:00 AM ET
    $KEY
    Major Banks
    Finance

    SEC Form SC 13G filed by Pacific Biosciences of California Inc.

    SC 13G - PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (0001299130) (Subject)

    11/26/24 8:27:01 PM ET
    $PACB
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    Amendment: SEC Form SC 13D/A filed by Paysafe Limited

    SC 13D/A - Paysafe Ltd (0001833835) (Subject)

    11/25/24 5:15:35 PM ET
    $PSFE
    Real Estate

    $ACCD
    $ADPT
    $AFRM
    $AGTI
    Financials

    Live finance-specific insights

    View All

    Affirm to announce third quarter fiscal year 2026 results on May 7, 2026

    Affirm Holdings, Inc. (NASDAQ:AFRM) today announced it will publish its third quarter fiscal year 2026 shareholder letter, including its financial results, on its investor relations website at https://investors.affirm.com/ on Thursday, May 7, 2026, after market close. The Company will host a conference call and webcast at 2:00pm PT that same day. Hosting the call will be Max Levchin (Founder and Chief Executive Officer), Michael Linford (Chief Operating Officer), and Rob O'Hare (Chief Financial Officer). A replay will be available on the investor relations website following the call. About Affirm Affirm's mission is to deliver honest financial products that improve lives. By building

    4/16/26 4:07:00 PM ET
    $AFRM
    Finance: Consumer Services
    Finance

    PacBio to Report First Quarter 2026 Financial Results on May 7, 2026

    MENLO PARK, Calif., April 16, 2026 (GLOBE NEWSWIRE) -- PacBio (NASDAQ:PACB) announced today that it will hold its quarterly conference call to discuss its first quarter 2026 financial results on Thursday, May 7, 2026, at 4:30 p.m. Eastern Time (1:30 p.m. Pacific Time). The call will be webcast and may be accessed on PacBio's website at https://investor.pacificbiosciences.com/. Date: Thursday, May 7, 2026, at 4:30 p.m. ET (1:30 p.m. PT)Listen live via internet or replay: https://investor.pacificbiosciences.com/ Toll-free: 1-888-349-0136 International: 1-412-317-0459 About PacBio PacBio (NASDAQ:PACB) is a premier life science technology company that designs, develops, and manufactures a

    4/16/26 4:05:00 PM ET
    $PACB
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    KEYCORP REPORTS FIRST QUARTER 2026 NET INCOME OF $486 MILLION, OR $0.44 PER DILUTED COMMON SHARE INCREASING 33% YEAR-OVER-YEAR

    Revenue of $1.95 billion, up 10% year-over-year, with noninterest income up 8%Net interest income up 11% year-over-year and 1% quarter-over-quarter despite seasonality impact; net interest margin of 2.87% increased 5 bps sequentiallyPeriod-end loans up $2.6 billion quarter-over-quarter, with commercial loans up $3.3 billion or 4%Credit quality remains strong - nonperforming assets were 63 bps and net charge-offs were 38 bpsCommon Equity Tier 1 ratio of 11.4%(a); repurchased $389 million of common shares during the quarterCLEVELAND, April 16, 2026 /PRNewswire/ -- KeyCorp (NYSE:KEY) announced net income from continuing operations attributable to Key common shareholders of $486 million, or $0.4

    4/16/26 6:30:00 AM ET
    $KEY
    Major Banks
    Finance